NCT07379580 A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa Status RECRUITING Phase PHASE2
NCT07377175 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. Status RECRUITING Phase PHASE1
NCT05995275 A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age Status COMPLETED Phase PHASE1/PHASE2
NCT05976100 Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years Status COMPLETED Phase PHASE1
NCT05935917 Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults Status COMPLETED Phase PHASE1
NCT05846243 Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years Status COMPLETED Phase PHASE2/PHASE3
NCT05762523 Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years Status COMPLETED Phase PHASE1
NCT04971109 Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days Status COMPLETED Phase PHASE3
NCT04957485 Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04485039 Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders Status COMPLETED Phase PHASE4
NCT04392739 Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG Status COMPLETED Phase PHASE4
NCT03972111 A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox Status WITHDRAWN Phase N/A
NCT02474589 A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat Status COMPLETED Phase PHASE3
NCT02038881 Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection Status COMPLETED Phase PHASE2
NCT01827371 Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE® Status COMPLETED Phase PHASE2
NCT01668537 A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects Status COMPLETED Phase PHASE2
NCT01540929 Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel Status COMPLETED Phase N/A
NCT01317238 Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers Status COMPLETED Phase PHASE3